Company Overview
Company Name
Eledon Pharmaceuticals
Address
United States
Website
eledon.comPhone
(555) 555-5555Approx. Annual Revenue
$42.8M
Employees
11
Established
2000
About Eledon Pharmaceuticals
Eledon is a United States-based company with approximately 11 employees, established in 2000. The company is focused on developing its lead compound, tegoprubart, an anti-CD40L antibody with potential to improve the longevity and quality of life for transplant recipients. Eledon is currently conducting clinical trials for tegoprubart in kidney transplantation and exploring its potential in other organ transplantation, including liver and xenotransplantation.